The U.S. CLEAN Future Could be a Sizable Catalyst for Microgrids
Palm Beach, FL – February 11, 2020 – The CLEAN (Climate Leadership and Environmental Action for our Nation’s) Future Act could be a substantial catalyst for microgrids. Reportedly, it will include grants and support for microgrids and energy storage, according to Microgrid Knowledge. “Among other things, the bill provides creates a grant program to develop […]
Biggest Trend Paying Dividends In Alcoholic Beverages Market Is Celebrity And Brand Endorsement
Palm Beach, FL – February 11, 2020 – The global alcoholic beverages market is expected to reach $1,684 billion by 2025, registering a CAGR of 2.0% to 3.1% through 2025 according to multiple industry reports. The growth of the global alcoholic beverages market is driven by increase in global young‐adult demographic, surge in disposable income, and […]
Biotech Brief: Global Diabetes Drug Market Could Reach $78 Billion By End Of 2026
Palm Beach, FL –February 11, 2020 – The global diabetes drugs market size was valued at USD $48,753.1 Million in 2018, is projected to reach USD 78,261.7 Million by the end of 2026, exhibiting a CAGR of 6.1%, according to industry reports. Rise in obesity, growing adoption of a sedentary lifestyle and an increase in […]
Global Medical Device Industry Bolstering Outstanding Growth Potentials
Palm Beach, FL – February 11, 202- There is no doubt that the global medical device market has been showing outstanding growth for the last few years and that it will continue to do so in the near future… and most likely beyond then. It also should see the North American market continue to dominate […]
Pediatric Brain Tumor Drug Market Is Growing Continuously and Could Reach US$1,659.4 Million by 2023
Palm Beach, FL – February 11, 2020 – Pediatric brain tumors are abnormal growths that arise in the brain during childhood. Although brain tumors are rare overall, they are the most common solid tumor among children. What’s important to remember is that children are not simply miniature adults. Brain tumors in children behave differently than brain […]
Iconic Brands’ Hooters Spirits Premium Line Now Available in Hooters Corporate Restaurants in 22 States
Expansion Plans for Placement of Hooters Spirits Include its Franchised Restaurants and Off-Premise Retail Distribution Amityville, NY – February 11, 2020 — Iconic Brands, Inc. (OTCQB: ICNB) (“Iconic” or the “Company”), today announced that its private-label Hooters Spirits products, a premium line of alcohol beverages that includes an array of vodka, gin, rum, tequila and whiskey options, is now […]
5G Infrastructure Could Spur $1.3 Trillion Global Media & Entertainment Market Over Next Decade
Palm Beach, FL – February 11, 2020 – A report commissioned by Intel and conducted by Ovum, predicted that 5G will represent 80 percent of wireless media revenues by 2028 and that nearly $3 trillion in cumulative revenue opportunities will be spurred by wireless technology from 2019-2028 and experiences enabled by 5G networks will account […]
Genprex and University of Pittsburgh Sign Exclusive License Agreement for Potentially Curative Gene Therapy Candidate for Diabetes
Company licenses patented diabetes gene therapy technology designed by researchers at the University of Pittsburgh Results from in vivo animal studies indicate that normal glucose levels in the blood may be restored for an extended period of time Company plans to partner for the clinical development and commercialization of this therapy in the U.S. and […]
Soliton Files Special 510(k) with FDA for its Generation II RAP Device
Key step towards limited launch mid-2020 Houston, TX – February 11, 2020 –Soliton, Inc., (NASDAQ: SOLY) (“Soliton” or the “Company”), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center (“MD Anderson”), today announced that it has filed for Special […]
CNS Pharmaceuticals Announces Collaboration with European Partner to Expand Clinical Trials to Pediatric Brain Tumors
In addition to potential upcoming Phase II clinical trial evaluating the efficacy of Berubicin in patients with Glioblastoma Houston, TX – February 11, 2020 – CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) (“CNS” or the “Company”), a biotechnology company specializing in the development of novel treatments for brain tumors, today announced its plan to initiate a […]
